Publications by authors named "Jason Wustner"

Claim this Profile
P
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies.
Juanita S Lopez, Mohammed Milhem, Marcus O Butler, Fiona Thistlethwaite, Brian A Van Tine, Jason Wustner

Cell Rep Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer.
Daniel J O'Shannessy, Katie Bendas, Charles Schweizer, Wenquan Wang, Earl Albone, Jason Wustner

Genomics· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and exposure-response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection.
Anubha Gupta, Ziad Hussein, Raffit Hassan, Jason Wustner, Julia D Maltzman

Cancer Chemother Pharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Katherine Rybinski, Hongxia Z Imtiyaz, Barrie Mittica, Brian Drozdowski, James Fulmer, Jason Wustner

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Luis A Diaz, Christina M Coughlin, Susan C Weil, Jean Fishel, Mrinal M Gounder, Jason Wustner

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer.
Colm Farrell, Charles Schweizer, Jason Wustner, Susan Weil, Masayuki Namiki

Cancer Chemother Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap.
Jason T Wustner, Susan Arnold, Martin Lock, James C Richardson, Vaughn B Himes

Mol Ther· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis